REQUEST A DEMO
Total
USD $0.00
Search more companies

Clover Biopharmaceuticals, Limited (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Clover Biopharmaceuticals, Limited Profile Updated: March 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Clover Biopharmaceuticals, Limited is a company located in Hong Kong. It was incorporated on July 15, 2010, with a registered capital of 700,000 yuan. The company obtained its business license on July 15, 2010, from the Yixing Administration for Industry and Commerce in Wuxi City, with the registration number 320282000245100. In February 2018, the company underwent a transformation from a limited liability company to a joint-stock company. The net assets as of November 30, 2017, audited by Zhongtianyun Certified Public Accountants (Special General Partnership), were used as the basis for the transformation, resulting in a total share capital of 75 million shares, with a face value of 1.00 yuan per share. The company's registered capital is 75 million yuan, as confirmed by the business license issued by the Wuxi Administrative Examination and Approval Bureau on May 11, 2018.

Headquarters
49F, Park Place, 1598-1601 West Nanjing Road, Jing'An District
Shanghai; Shanghai;

Contact Details: Purchase the Clover Biopharmaceuticals, Limited report to view the information.

Website: http://www.cloverbiopharma.com

Basic Information
Total Employees:
Purchase the Clover Biopharmaceuticals, Limited report to view the information.
Outstanding Shares:
Purchase the Clover Biopharmaceuticals, Limited report to view the information.
Registered Capital:
Purchase the Clover Biopharmaceuticals, Limited report to view the information.
Financial Auditors:
Purchase the Clover Biopharmaceuticals, Limited report to view the information.
Incorporation Date:
October 31, 2018
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
7.05%
Purchase this report to view the information.
5.41%
Purchase this report to view the information.
5.13%
Purchase this report to view the information.
3.8%
Purchase this report to view the information.
2.72%
Subsidiaries
Chengdu Fuya Enterprise Management Co., Ltd. ('Chengdu Fuya') (China)
100%
Clover Biopharmaceuticals (Beijing) Co., Ltd. ('Beijing Clover') (China)
100%
Clover Biopharmaceuticals (Hong Kong) Co., Limited ('HK Clover')
100%
Company Performance
Financial values in the chart are available after Clover Biopharmaceuticals, Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-40.94%
Total equity
-83.83%
Return on Equity (ROE)
N/A
Debt to Equity Ratio
1551.4%
Quick Ratio
-0.6%
Cash Ratio
-0.34%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?